Skip to main content

Table 2 Demographic data of the study population and divided by the two cohorts

From: Introduction of national guidelines for restrictive blood transfusion threshold for hip fracture patients––a consecutive cohort study based on complete follow-up in national databases

 

Study population

Liberal group

Restrictive group

 
 

n

%

n

%

n

%

p<

Total

2908

100

1494

100

1414

100

 

Age

 65–74

590

20

308

21

282

20

 

 75–84

1018

35

514

34

504

36

0.766

 ≥ 85

1300

45

672

45

628

44

 

Sex

 Female

2.014

69

1065

71

949

67

0.015

 Male

894

31

429

29

465

33

CCI

 None (0)

1019

35

526

35

493

35

0.800

 Low (1–2)

1238

43

641

43

597

42

 High (≥ 3)

651

22

327

22

324

23

BMI

 < 18.5

278

10

153

10

125

9

 

 18.5–24.9

1269

44

645

43

624

44

 

 25–29.9

686

24

341

23

345

24

0.433

 ≥ 30

210

7

102

7

108

8

 

 Missing

465

16

253

17

212

15

 

Prescription medicine

 NSAID

223

8

137

9

86

6

0.002

 Diabetes

330

11

166

11

164

11

0.66

 Anticoagulant

1191

41

620

42

571

41

0.58

 Antihypertensive

1457

50

757

51

700

49

0.58

 Statin

720

25

356

24

364

26

0.22

 Glucocorticoid

172

6

89

6

83

6

0.94

 Depression medicine

888

31

486

33

402

29

0.02

 COPD medicine

399

14

209

14

190

13

0.69

Type of fracture

 Femoral neck

1693

59

875

59

818

58

0.851

 Pertrochanteric

948

32

480

33

468

33

 Subtrochanteric

267

9

139

9

128

9

Type of surgery

 Cannulated screws

383

13

206

14

177

13

0.001

 Sliding hip screw

677

23

404

27

273

19

 Intramedullary nail

787

27

357

24

431

30

 Arthroplasty

1018

35

506

34

512

36

 Miscellaneous

42

1

21

1

21

1

Time to surgery

 < 24 h

2050

72

1104

74

946

69

 

 24–48 h

636

22

317

21

319

23

0.001

 > 48 h

180

6

65

4

115

8

 
  1. NSAID nonsteroidal anti-inflammatory drug, COPD chronic obstructive pulmonal disease